Leinco Technologies

Recombinant Human Procalcitonin

Product Code:
 
LEI-P236
Product Group:
 
Recombinant Proteins
Host Type:
 
Human
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
The protein should be stored at -20°C.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-P236-10ug10 ug£307.00
Quantity:
LEI-P236-100ug100 ug£915.00
Quantity:
LEI-P236-500ug500 ug£4,181.00
Quantity:
LEI-P236-1mg1 mg£6,906.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Format:
The protein is 0.2 um filtered and supplied in 1x PBS containing 50% glycerol.
Formulation:
The protein is 0.2 um filtered and supplied in 1x PBS containing 50% glycerol.
Long Description:
Procalcitonin (PCT) is a precursor protein of the hormone calcitonin.1 PCT is found in elevated concentrations in the blood circulation during systemic bacterial, fungal or protozoal infection. It is a marker of severe bacterial infections and organ failure due to sepsis.2 In contrast to Calcitonin that is primarily synthesized in the thyroid, Procalcitonin is the prohormone that is synthesized in many different tissues of infected organs. High Procalcitonin levels can also be seen in non bacterial diseases such as malaria, severe trauma, burns and medullar carcinoma of the thyroid. Procalcitonin has improved the diagnosis of bacterial infections.3 Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients with severe sepsis. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistances and costs in intensive care medicine.4
Purity:
>95% by SDS Page and HPLC
Target:
Procalcitonin

References

1. Schmidt, J. et al. (1999) Crit Care 3: 452. Nobori, T. et al. (2008) Shock 3. M?ller, B. et al. (2008) Ther Umsch 65: 5594. Von Spiegel, T. et al. (2009) Langenbecks Arch Surg 394: 221